发明名称 Menetelmä 2-aryylipropionihappojen valmistamiseksi
摘要 A process for the preparation of a pharmaceutically active compound in a stereospecific form of the formula <CHEM> or a pharmaceutically acceptable salt or ester thereof, like an alkali metal salt or an alkaline earth metal salt or a pivaloyl ester, wherein R1 represents an optionally substituted aryl group such as a phenyl or naphthyl group optionally included in a heterocyclic ring system, which is optionally substituted, or represents a heteroaromatic ring system containing in addition to carbon atoms one or more atoms selected from nitrogen, sulphur and oxygen, this ring system being optionally substituted, which comprises subjecting a compound of the formula <CHEM> wherein R2 is an ester residue and preferably an alkyl group optionally substituted, to the action of a micro-organism having the ability for stereoselective hydrolysis of compound (II) into compound (I), having at least 80% by weight the S-configuration, and if desired converting compound (I) into the pharmaceutically acceptable salt or ester thereof.
申请公布号 FI90565(C) 申请公布日期 1994.02.25
申请号 FI19870000035 申请日期 1987.01.05
申请人 SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.,;DSM N.V., 发明人 BERTOLA,MAURO ATTILIO;MARX,ARTHUR FRIEDRICH;KOGER,HEIN SIMON;QUAX,WILHELMUS JOHANNES;VAN DER LAKEN,CORNELIS JACOBUS;PHILLIPS,GARETH THOMAS;ROBERTSON,BRIAN WILLIAM;WATTS,PETER DOUGLAS
分类号 C12N15/09;A61K31/19;A61K31/33;A61P25/04;A61P29/00;C07C57/30;C07D209/46;C07H21/04;C12N1/20;C12N1/21;C12N9/18;C12N15/00;C12P7/40;C12P17/00;C12P41/00;C12R1/06;C12R1/10;C12R1/125;C12R1/19;C12R1/38;C12R1/385;C12R1/39;C12R1/40;C12R1/465;C12R1/785;(IPC1-7):C12P7/40;C12P1/21;C12P15/55;C12P9/18;C12N15/55;C12P1/20 主分类号 C12N15/09
代理机构 代理人
主权项
地址